Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Oct;134(1):138-42.
doi: 10.1046/j.1365-2249.2003.02262.x.

Matrix metalloproteinases production in malignant pleural effusions after talc pleurodesis

P D'Agostino  1 , A Rao Camemi, R Caruso, F Arcoleo, A Cascio, A Dolce, E Sacco, G Cangemi, T di Rosa, P Moceo, E Cillari
Affiliations

Matrix metalloproteinases production in malignant pleural effusions after talc pleurodesis

P D'Agostino et al. Clin Exp Immunol. 2003 Oct.

Abstract

In this study we have evaluated the modifications of matrix metalloproteinases (MMPs) in malignant pleural fluids taken from patients suffering from lung cancer and treated with intrapleural talc instillation to induce pleurodesis. Furthermore, we have analysed the variations of some inflammatory mediators (C-reactive protein, alpha-1 antitrypsin) and of a protein (plasminogen) involved in MMP activation. In all patients the clinical improvement after talc pleurodesis was followed by a reduction in MMP-1, TIMP-1, C-reactive protein, alpha-1 antitrypsin and plasminogen activity. Furthermore, MMP-9 levels were variable; in fact, in some patients they were high at the beginning of treatment, in others they increased a few days after pleurodesis induction. These inhibitory effects of talc on MMP-1 and inflammatory mediators associated with the reduction of pleural effusion could constitute an effective means to evaluate the evolution of the treatment.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Levels of pro-MMP-1 in pleural effusions. pro-MMP-1 concentration was evaluated using ELISA at different times after talc pleurodesis. Each column indicates the different time of pleural fluid harvesting following the treatment. The white column shows the value of pro-MMP-1 before intrapleural talc instillation, the black column the last withdrawal and shaded and hatched columns intermediate points. Data are expressed as means of three determinations in three different aliquots of each sample; the mean variations were less than 10% per patient. Time scale: every 3 days.
Fig. 2
Fig. 2
Levels of CRP in pleural effusions. CRP concentrations were determined by nephelometric analysis at different times after talc pleurodesis. Each column indicates the different time of pleural fluid harvesting following the treatment. The white column shows the value of CRP before intrapleural talc instillation, the black column the last withdrawal and shaded and hatched columns intermediate points. Data are expressed as means of three determinations in three different aliquots of each sample; the mean variations were less than 10% per patient. Time scale: every 3 days.
See this image and copyright information in PMC

References

    1. Prevost A, Costa B, Elamarti R, et al. Long-term effect and tolerance of talc slurry for control of malignant pleural effusions. Oncol Rep. 2001;8:1327–31. - PubMed
    1. Mager HJ, Maesen B, Verzijlbergen F, Schramel F. Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis. Lung Cancer. 2002;36:77–81. - PubMed
    1. Cheng DS, Rogers J, Wheeler A, Parker R, Teixeira L, Light RW. The effects of intrapleural polyclonal anti-tumor factor alpha (TNF alpha) Fab fragments on pleurodesis in rabbits. Lung. 2000;178:19–29. - PubMed
    1. Lee YC, Lane KB. The many faces of transforming growth factor-beta in pleural diseases. Opin Pulm Med. 2001;7:173–9. - PubMed
    1. Hack CE, Wolbink GJ, Schalkwijk C, Speijer H, Hermens WT, van den Bosch H. A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells. Immunol Today. 1997;18:111–5. - PubMed

MeSH terms